Cyanotype Bio
ActiveUnlocking Chemical Discovery In The Plant Kingdom
What it does
Consumer and pharma supply chains are threatened by ecosystem loss and petrochemical dependence, with 97% of plant bioactives still untapped. Our AI-driven discovery and biomanufacturing platform unlocks novel ingredients using plant cell fermentation, displacing petrochemical production and wild harvests. Our founding team is backed by YC and Collab Fund, with our first LOI from a $B personal care brand and F500 negotiations underway. We’re protecting biodiversity and decarbonizing supply chains with the next generation of ingredients.
Next to it in Healthcare and bio · AI plant biotech discovery
- Atomistic InsightsAlchemist Accelerator Alchemist Class 39
Harnessing Protein Dynamics For Breakthrough Medicines
- Augment BiologicsSOSV SOSV IBSF 25H2 2025
AI-guided glycoprotein drug design with site-specific glycan writing
- Great Bay Bio 大湾生物Plug and Play PnP 2025
By utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long timelines, high costs, and low success rates in drug development.
- Aperture BioTechstars TS 2023
Aperture Bio
- PolybiomicsPlug and Play PnP 2025
Polybiomics enables simultaneous measurements of multiple cellular features from the same sample in real-time.
- Elnora AI, Inc.Plug and Play PnP 2025
Elnora is an AI co-pilot for biomedical lab protocols that learns from every experiment to accelerate drug discovery.
- CytodymeTechstars TS 2025
Cytodyme
- BiolincoTechstars TS 2026
Biolinco — Cell Line Development at Scale